Abstract:Mu Wang, 1, 2, &ast Jian Guo, 3, &ast Ailsa L Hart, 4 Jia V Li 1 1 Section of Nutrition, Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, W12 0NN, UK; 2 Department of Neurology, Shanxi Provincial People's Hospital, the Affiliated People's Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, 030012, People's Republic of China; 3 Department of General Surgery, Shanxi Provincial People's Hospital, the Affiliated People's Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, 030012, People's Republic of China; 4 IBD Unit, St. Mark's Hospital, London, HA1 3UJ, UK &astThese authors contributed equally to this work Correspondence: Jia V Li, Section of Nutrition, Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, W12 0NN, UK, Tel +44 20 7594 3230, Email Purpose: Indole-3-aldehyde (IAld) has been shown to improve intestinal epithelial barrier (IEB) function through the aryl hydrocarbon receptor (AhR) in murine colitis models. However, the impact of IAld on intestinal tissue inflammation remains unexplored. This study aimed to investigate the effects of IAld on the inflammatory responses of the gut both in vivo and in vitro and probe the mechanisms by which IAld attenuates colitis. Methods: The effects of IAld on phenotypic changes, pro-inflammatory cytokines, IEB functions and the faecal bacterial composition in mice with dextran sulfate sodium salt (DSS)-induced colitis were assessed. Macrophage cells and intestinal epithelial cells were stimulated with lipopolysaccharide (LPS), and the effects of IAld on the inflammatory responses and IBE functions were measured. Results: IAld reduced IL-6, IL-1β and TNF-α protein levels in both colonic tissues from the mice with colitis and LPS-stimulated macrophage cells. The IAld-mediated reduction of IL-6 but not IL-1β and TNF-α was through AhR activation. Furthermore, nuclear factor-κB pathway was found to be inhibited by IAld treatment via AhR activation both in vivo and in vitro. Gut permeability was significantly improved by IAld in both DSS-treated mice and LPS-stimulated Caco-2 cells. This observation is consistent with downregulation of phosphorylated myosin light chain through AhR activation. IAld did not appear to have an effect on the bacterial composition in mice with colitis despite the reduced colonic inflammatory responses. Conclusion: IAld improved DSS-induced colitis by inhibiting the inflammatory responses and restoring IEB function, partially via AhR activation. This work provided insight into the function of IAld in modulating gut inflammation. Keywords: indole-3-aldehyde aryl hydrocarbon receptor intestinal inflammation Graphical Ulcerative colitis (UC), a type of inflammatory bowel disease (IBD), is chronic immune-mediated inflammation occurring in the colon and rectum. 1 The main contributing factors to the pathogenesis of UC include an abnormal immune response of the mucosa and impaired intestinal epithelial barrier (IEB) functions. 1 These two pathogenic features result in devastating clinical consequences, such as rectal bleeding and diarrhoea. Although immunomodulators have frequently been used in treating patients with UC, therapeutic strategies remain a challenge owing to limited treatment options. 2 Recent advances in characterising gut microbial metabolism and metabolite functions have highlighted several microbial metabolites that improve intestinal homeostasis, including short-chain fatty acids (SCFAs), bile acid derivatives such as isoallolithocholic acid (isoalloLCA) 3 and tryptophan (Trp) metabolites. 4 Trp is an essential amino acid that is exclusively supplied by diet. Trp is metabolised in the mammalian gut in three main pathways, including the kynurenine pathway, serotonin pathway and through the bacterial pathway to produce indole and indole derivatives, 5 eg, indole-3-pyruvate (IPyA), indole-3-aldehyde (IAld), and indole propionic acid (IPA). 6 A lower level of serum Trp was observed in patients with UC compared to healthy subjects. 7 In addition, faecal levels of Trp, kynurenine and indole-3-acetic acid (IAA) in patients with UC were significantly different from those in healthy individuals. 8 Trp supplementation to mice with colitis alleviated the intestinal inflammation. 9,10 The anti-inflammatory effects of Trp and its metabolites such as IPA on experimental colitis have been proposed to occur through -Abstract Truncated-

Small Molecule Tyrosine Kinase Inhibitors for the Treatment of Intestinal Inflammation

Indol-3-Carbinol and Quercetin Ameliorate Chronic DSS-Induced Colitis in C57BL/6 Mice by AhR-Mediated Anti-Inflammatory Mechanisms

Intermittent Fasting Alleviates Risk Markers in a Murine Model of Ulcerative Colitis by Modulating the Gut Microbiome and Metabolome

The Tryptophan Metabolite Indole-3-Carboxaldehyde Alleviates Mice with DSS-Induced Ulcerative Colitis by Balancing Amino Acid Metabolism, Inhibiting Intestinal Inflammation, and Improving Intestinal Barrier Function

Evaluating the Anti-inflammatory Efficacy of a Novel Bipyrazole Derivative in Alleviating Symptoms of Experimental Colitis

Gut Protective Effect from D-Methionine or Butyric Acid against DSS and Carrageenan-Induced Ulcerative Colitis

Aloe-emodin alleviates inflammatory bowel disease in mice by modulating intestinal microbiome homeostasis via the IL-4/IL-13 axis

Taurodeoxycholate ameliorates DSS-induced colitis in mice

Inhibition of Phosphoinositide 3-Kinase Ameliorates Dextran Sodium Sulfate-Induced Colitis in Mice

P080 ADS024 attenuates weight loss and decreases disease activity in DSS-induced colitis

Meisoindigo Attenuates Dextran Sulfate Sodium-Induced Experimental Colitis Via Its Inhibition of TAK1 in Macrophages.

Methyl cinnamate protects against dextran sulfate sodium-induced colitis in mice by inhibiting the MAPK signaling pathway

Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels

EVALUATING THE PRE-CLINICAL EFFICACY OF VT1021 (A CLINICAL STAGE DRUG CANDIDATE) IN MULTIPLE EXPERIMENTAL MODELS OF INFLAMMATORY BOWEL DISEASE

Dihydromyricetin alleviates intestinal inflammation by changing intestinal microbial metabolites and inhibiting the expression of the MyD88/NF‐κB signaling pathway

Isochlorogenic Acid A Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice Through STAT3/NF-кB Pathway.

Analysis of Intestinal Microflora and Metabolites From Mice With DSS-Induced IBD Treated With Schistosoma Soluble Egg Antigen

Amelioration of Dextran Sodium Sulfate-Induced Colitis in Mice through Oral Administration of Palmitoylethanolamide

The Protective Effect and Mechanism of Aornia Melanocarpa Elliot Anthocyanins on IBD Model Mice

Isosteviol Sodium Exerts Anti-Colitic Effects on BALB/c Mice with Dextran Sodium Sulfate-Induced Colitis Through Metabolic Reprogramming and Immune Response Modulation

Indole-3-Aldehyde Reduces Inflammatory Responses and Restores Intestinal Epithelial Barrier Function Partially via Aryl Hydrocarbon Receptor (AhR) in Experimental Colitis Models